Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

August 30, 2026

Study Completion Date

August 30, 2026

Conditions

Thoracic Insufficiency Syndrome

Interventions

DEVICE

Xenon-129

Patients will undergo a hyperpolarized MRI with administered Xenon gas

Trial Locations (1)

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors

collaborator

Xemed LLC

INDUSTRY

lead

Patrick Cahill, MD

OTHER

NCT04977830 - Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients | Biotech Hunter | Biotech Hunter